Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma. - Wikidata - awgldk - TriplyDB

Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.

Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.

http://www.wikidata.org/entity/Q37002698

about

Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma.Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report.

P2860

Q41622513-55B16F86-D3D5-4CC6-A703-8C51EAD0E39C Q50324271-0E6EE2D0-318D-4EF2-A77E-872A20F9D238

P2860

Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.

http://www.wikidata.org/entity/Q37002698

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@en

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@nl

type

label

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@en

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@nl

prefLabel

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@en

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@nl

P1433

Q37002698-9898407A-581C-402C-BA89-6F00C1EB809E

P1476

Q37002698-1FBF7576-F2B4-4989-BB5F-01248A3728C2

P2093

Q37002698-462255BF-6B8B-4491-9784-2ACE32433079

Q37002698-7CC2D2EB-441C-442A-B620-78E1CAAA9347

Q37002698-8872A88F-1EF2-4B6B-9BBA-8FAA93516AE5

Q37002698-98AEFE98-B150-4B31-AAA7-4EE423588264

Q37002698-AEE100AA-4530-4372-842B-3986A64CB018

Q37002698-E07E93C7-EC8A-4FF5-BD9E-A4917CF872A6

P2860

Q37002698-00A94104-AC56-44CC-951E-6E1FED46BD80

Q37002698-08709F75-0473-413A-980E-72FD9398C17E

Q37002698-0ACADFCE-5600-4D7E-8E56-BA150FF47441

Q37002698-10189F68-0CA3-4047-9093-3BA5E1424757

Q37002698-13E159F5-03B8-41D7-9F01-D7C530BF67E7

Q37002698-1727C217-91DE-46E3-A1F0-52BB6973BBA2

Q37002698-198FE361-43D3-41F0-A6A9-D1D61C467589

Q37002698-30A3590D-82A3-46E2-B52C-856FE2CA523D

Q37002698-31549270-3F63-429F-9EF6-43C4F911FE7C

Q37002698-5D4C6F27-69B9-4223-A8B5-339078E8976E

P304

Q37002698-24ED14BA-21BC-4FD5-8586-0FD34A5814D3

P31

Q37002698-6DFF2410-1CEF-4799-8312-B3B451583046

P356

Q37002698-7A14178C-8CBC-446F-9FBF-68D6EF66D566

P433

Q37002698-EDDD6835-8837-47F9-ABE5-CC405F91F5EE

P478

Q37002698-8BC7A5AC-28E1-4DE7-841F-FA876CFA5051

P577

Q37002698-6FB8E05D-C9BF-4A64-9972-C4CD755D7C71

P698

Q37002698-2027D97D-AC6B-424D-B8CD-2F915729C929

P932

Q37002698-06758612-23E6-4ED8-AA3C-49AA66457829

P356

P1433

Oncology Letters

P1476

Efficacy of RetroNectin-activa ...... anced hepatocelluar carcinoma.

@en

P2093

Daniel B Kellner

http://www.w3.org/2001/XMLSchema#string

Lingdi Zhao

http://www.w3.org/2001/XMLSchema#string

Linping Xu

http://www.w3.org/2001/XMLSchema#string

Quanli Gao

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Yaomei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.

Epidemiology of primary liver cancer.

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

Two hundred years of cancer research.

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.

P304

707-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4629

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27347204

http://www.w3.org/2001/XMLSchema#string

P932

4907280

http://www.w3.org/2001/XMLSchema#string